高压造影注射器市场 - 全球产业规模、份额、趋势、机会及预测（按产品、类型、应用、最终用途、地区和竞争格局划分），2021-2031年

全球高压造影注射器市场预计将从 2025 年的 2.8235 亿美元成长到 2031 年的 4.3236 亿美元，复合年增长率达到 7.36%。

这些专用设备旨在将造影剂精确输送到血管内，从而改善电脑断层扫描 (CT)、磁振造影(MRI) 和血管造影术等诊断程序中的组织显像效果。市场成长的主要驱动力是全球慢性疾病（例如心血管疾病和癌症）发病率的上升，这些疾病需要频繁且准确的诊断影像才能有效管理。此外，全球人口老化也持续推高了对这些重要治疗方法的需求。为了强调这项需求，美国癌症协会在 2024 年预测，到 2050 年，全球癌症负担可能达到每年约 3,500 万例新增病例，凸显了对可扩展诊断影像能力的迫切需求。

然而，市场扩张的一大障碍是与实施和营运先进注射器系统相关的高昂成本。这些自动化设备的高昂价格，加上耗材的持续成本，给医疗预算带来了沉重负担，尤其是在报销有限的发展中地区。这种经济压力会阻碍高性能注射器技术的广泛应用，常常迫使注重成本的医疗机构依赖效率较低的手动给药技术。

市场驱动因素

全球范围内电脑断层扫描 (CT) 和磁振造影(MRI) 检查数量的不断增长是推动市场发展的主要因素。随着医疗机构致力于提高复杂疾病诊断的准确性，对横断面影像的需求激增，直接增加了对可靠造影输送系统的需求。这一趋势在近期统计数据中得到了体现。根据英国国家医疗服务体系 (NHS England) 于 2024 年 11 月发布的《2023/24 年度诊断影像资料集统计》，CT 检查数量年增 8.4%，达到 770 万例；MRI 检查数量年增 8.1%，达到 440 万例。日益增长的工作量迫使医疗机构投资于高通量输液设备，以加快患者周转速度。此外，西门子医疗在 2024 年 11 月发布的「2024 年第四季财务业绩」中报告称，其影像部门的销售额同比增长 7.7%，表明全球对诊断基础设施的投资持续增长。

输液设备系统的技术创新，促进了自动化和更智慧的操作，也推动了市场成长。製造商正致力于开发可与放射资讯系统 (RIS) 整合的设备，以自动追踪药物剂量并最大限度地减少造影剂浪费，从而提高营运效率。主要产业参与者的大量研发投入支持了向智慧生态系统的转变。例如，GE医疗于2024年2月发布的2023年度报告重点介绍了其超过10亿美元的研发投资，旨在加速精准医疗和平台标准化。这些投资正在推动具有个人化剂量设定和即时监测功能的智慧注射器的开发，鼓励医疗机构从传统硬体升级到可简化临床工作流程的先进连网设备。

市场挑战

高压造影输液设备的高昂实施和营运成本是限制市场成长的一大障碍。这些系统需要大量的初始投资，而且通常还需要持续投入资金购买注射器和输液管等专用耗材。对于小规模的医疗机构和医疗报销政策严格的地区的医院而言，这种双重经济负担尤其沉重。因此，面临有限资本投资预算的管理者往往选择维持现有的手动通讯协定，而不是升级到自动化系统。

这些经济压力有效地减缓了整个产业对新技术的采用。美国医院协会 (AHA) 预测，到 2024 年，医院总支出将年增约 6%，这将进一步减少可用于购买非必需医疗设备的财务空间。这些预算限制迫使采购部门优先考虑必要的营运成本，而非新的诊断设备。这种财务状况限制了输液设备的销售量，并阻碍了其在价格敏感地区的市场渗透率提升。

市场趋势

关键市场趋势包括注重环保和减少废弃物的组件设计，这源自于医疗保健产业减少环境足迹和管理供应链风险的需求。製造商正在加速从传统的一次性系统向先进的无针和多患者耗材工作流程的过渡。这项转变旨在显着减少医疗塑胶废弃物，并最大限度地减少未使用的造影剂，从而应对环境挑战和供不应求。这项永续性措施正成为一项竞争标桿，Bracco 的《2024 年永续发展报告》重点介绍了公司负责任的生产实践，使其荣获 EcoVadis 白金奖，并跻身全球永续企业前 1%，这印证了该行业对绿色技术的日益重视。

同时，人工智慧演算法的整合正在将注射器从简单的给药装置转变为互联的智慧诊断节点。这一趋势不仅限于基本的连接，还将深度学习模型直接融入成像生态系统，从而在不影响诊断品质的前提下增强影像重建并减少造影造影用量。这项技术演进得益于商业环境的支持，软体改进的价值与硬体本身不相上下。近期的数据也印证了这一数位转型的规模。根据拜耳公司2024年12月发布的「RSNA 2024」新闻稿，2023年全球医疗影像人工智慧收入将超过7.34亿美元，这显示现代造影给药系统所依赖的数位基础设施正在迅速扩展，以优化临床疗效。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 高压造影注射器的全球市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（输液系统、耗材、注射器、导管等）
  • 依类型（单头注射器、双头注射器、无针注射器）
  • 依应用领域（介入性心臟病学、介入性放射学、血管内外科、介入性神经放射学）
  • 依最终用途（医院、诊断中心、门诊手术中心）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美高压造影注射器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲高压造影注射器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区高压造影注射器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲高压造影注射器市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲高压造影注射器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球高压造影注射器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Bracco SpA
• Guerbet AG（Guerbet Group）
• Medtron AG
• GE HealthCare Technologies Inc.
• Bayer Healthcare LLC
• NemotoKyorindo Co., Ltd
• ulrich GmbH & Co. Kg
• Sino Medical-Device Technology Co., Ltd.
• APOLLO RT Co. Ltd.
• Shenzhen Seacrown Electromechanical Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global High Pressure Contrast Media Injectors Market is projected to expand from USD 282.35 Million in 2025 to USD 432.36 Million by 2031, achieving a CAGR of 7.36%. These specialized devices are engineered to precisely deliver radiopaque contrast agents into the vascular system, thereby improving tissue visualization during diagnostic procedures like Computed Tomography, Magnetic Resonance Imaging, and angiography. Market growth is largely driven by the rising global incidence of chronic conditions, such as cardiovascular diseases and cancer, which require frequent and accurate diagnostic imaging for effective management. Furthermore, the aging global population continues to sustain the demand for these essential interventions. Highlighting this need, the American Cancer Society projected in 2024 that the global cancer burden could reach approximately 35 million new cases annually by 2050, emphasizing the urgent requirement for scalable imaging capacities.

However, a major obstacle to market expansion is the significant cost associated with acquiring and operating advanced injector systems. The high price of these automated units, combined with the ongoing expense of single-use consumables, exerts considerable pressure on healthcare budgets, especially in developing regions with limited reimbursement frameworks. This financial strain can hinder the widespread adoption of high-performance injector technology, often compelling cost-sensitive facilities to depend on less efficient manual administration techniques.

Market Driver

The increasing global volume of Computed Tomography and Magnetic Resonance Imaging procedures serves as a primary catalyst for the market. As healthcare providers aim to enhance diagnostic precision for complex conditions, the demand for cross-sectional imaging has surged, directly heightening the need for reliable contrast delivery systems. This trend is reflected in recent statistics; according to NHS England's November 2024 'Diagnostic Imaging Dataset Annual Statistical Release 2023/24', the number of CT scans rose by 8.4% to 7.7 million, and MRI scans increased by 8.1% to 4.4 million compared to the prior year. This growing workload drives facilities to invest in high-throughput injectors capable of handling rapid patient turnover. Furthermore, Siemens Healthineers reported a 7.7% comparable revenue growth in its Imaging segment in the November 2024 'Q4 Fiscal Year 2024' earnings release, indicating sustained global investment in diagnostic infrastructure.

Technological advancements in automated and smart injector systems also significantly drive market growth. Manufacturers are increasingly focusing on devices that integrate with Radiology Information Systems to automate dosage tracking and minimize contrast waste, thereby improving operational efficiency. This move toward intelligent ecosystems is backed by substantial R&D investments from key industry players. For instance, GE HealthCare's February 2024 '2023 Annual Report' highlighted an investment of over $1 billion in research and development to accelerate precision care and standardize platforms. Such funding facilitates the creation of smart injectors with personalized dosing and real-time monitoring capabilities, encouraging healthcare facilities to upgrade from legacy hardware to sophisticated, connected units that streamline clinical workflows.

Market Challenge

The high acquisition and operational costs associated with high-pressure contrast media injectors constitute a significant barrier to market growth. These systems require a substantial initial capital investment, which is often compounded by the recurring expense of proprietary consumables like syringes and tubing sets. This dual financial burden poses a particular challenge for smaller healthcare facilities and hospitals in regions with restrictive reimbursement policies. Consequently, when faced with limited capital expenditure budgets, administrators frequently choose to maintain existing manual protocols rather than upgrading to automated systems.

These economic pressures effectively decelerate the adoption of new technology across the sector. The American Hospital Association projected in 2024 that total hospital expenses would rise by nearly 6 percent compared to the previous year, further tightening the financial margins available for discretionary medical equipment purchases. Such budgetary constraints force procurement departments to favor essential operational costs over new diagnostic machinery. This financial climate suppresses the sales volume of injector units and impedes broader market penetration in price-sensitive geographies.

Market Trends

A key trend in the market is the focus on eco-friendly and waste-minimizing component design, driven by the healthcare sector's need to reduce environmental impact and manage supply chain risks. Manufacturers are increasingly moving away from traditional single-use disposable systems in favor of advanced syringeless and multi-patient consumable workflows. This transition is designed to significantly lower the volume of medical-grade plastic waste and minimize unused contrast media, addressing both ecological concerns and frequent iodine supply shortages. This commitment to sustainability has become a competitive standard; Bracco's 'Sustainability Report 2024' noted that its responsible manufacturing efforts earned an EcoVadis Platinum Medal, placing it in the top 1% of sustainable companies globally and validating the industry's growing emphasis on green technology.

Concurrently, the integration of AI algorithms is transforming injectors from simple delivery mechanisms into intelligent, interconnected diagnostic nodes. This trend extends beyond basic connectivity by embedding deep learning models directly into the imaging ecosystem to enhance image reconstruction, enabling reduced contrast volumes without sacrificing diagnostic quality. This technological evolution is supported by a commercial landscape where software enhancements are becoming as valuable as the hardware itself. The scale of this digital shift is illustrated by recent data; Bayer's December 2024 'RSNA 2024' press release reported that the global medical imaging AI sector generated sales exceeding $734 million in 2023, signaling a rapid expansion of the digital infrastructure that modern contrast delivery systems are now utilizing to optimize clinical outcomes.

Key Market Players

• Bracco S.p.A.
• Guerbet AG (Guerbet Group)
• Medtron AG
• GE HealthCare Technologies Inc.
• Bayer Healthcare LLC
• NemotoKyorindo Co., Ltd
• ulrich GmbH & Co. Kg
• Sino Medical-Device Technology Co., Ltd.
• APOLLO RT Co. Ltd.
• Shenzhen Seacrown Electromechanical Co., Ltd.

Report Scope

In this report, the Global High Pressure Contrast Media Injectors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

High Pressure Contrast Media Injectors Market, By Product

• Injector Systems
• Consumables
• Syringes
• Tubing
• Others

High Pressure Contrast Media Injectors Market, By Type

• Single Head Injectors
• Dual Head Injectors
• Syringeless Injectors

High Pressure Contrast Media Injectors Market, By Application

• Interventional Cardiology
• Interventional Radiology
• Endovascular Surgery
• Interventional Neuroradiology

High Pressure Contrast Media Injectors Market, By End Use

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

High Pressure Contrast Media Injectors Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global High Pressure Contrast Media Injectors Market.

Available Customizations:

Global High Pressure Contrast Media Injectors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global High Pressure Contrast Media Injectors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Injector Systems, Consumables, Syringes, Tubing, Others)
  • 5.2.2. By Type (Single Head Injectors, Dual Head Injectors, Syringeless Injectors)
  • 5.2.3. By Application (Interventional Cardiology, Interventional Radiology, Endovascular Surgery, Interventional Neuroradiology)
  • 5.2.4. By End Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America High Pressure Contrast Media Injectors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States High Pressure Contrast Media Injectors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada High Pressure Contrast Media Injectors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico High Pressure Contrast Media Injectors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe High Pressure Contrast Media Injectors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany High Pressure Contrast Media Injectors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. France High Pressure Contrast Media Injectors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom High Pressure Contrast Media Injectors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy High Pressure Contrast Media Injectors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain High Pressure Contrast Media Injectors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia Pacific High Pressure Contrast Media Injectors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China High Pressure Contrast Media Injectors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India High Pressure Contrast Media Injectors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan High Pressure Contrast Media Injectors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea High Pressure Contrast Media Injectors Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia High Pressure Contrast Media Injectors Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. Middle East & Africa High Pressure Contrast Media Injectors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia High Pressure Contrast Media Injectors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE High Pressure Contrast Media Injectors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa High Pressure Contrast Media Injectors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. South America High Pressure Contrast Media Injectors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil High Pressure Contrast Media Injectors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia High Pressure Contrast Media Injectors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina High Pressure Contrast Media Injectors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global High Pressure Contrast Media Injectors Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bracco S.p.A.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Guerbet AG (Guerbet Group)
• 15.3. Medtron AG
• 15.4. GE HealthCare Technologies Inc.
• 15.5. Bayer Healthcare LLC
• 15.6. NemotoKyorindo Co., Ltd
• 15.7. ulrich GmbH & Co. Kg
• 15.8. Sino Medical-Device Technology Co., Ltd.
• 15.9. APOLLO RT Co. Ltd.
• 15.10. Shenzhen Seacrown Electromechanical Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer